143 related articles for article (PubMed ID: 24687550)
1. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.
Zhou X; Yuan B; Yuan W; Wang C; Gao R; Wang J
Tumour Biol; 2014 Jul; 35(7):6539-47. PubMed ID: 24687550
[TBL] [Abstract][Full Text] [Related]
2. The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.
Weng M; Song F; Chen J; Wu J; Qin J; Jin T; Xu J
Tumour Biol; 2015 Feb; 36(2):959-66. PubMed ID: 25315189
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy.
Yang C; Gao R; Wang J; Yuan W; Wang C; Zhou X
Tumour Biol; 2014 Jul; 35(7):6357-63. PubMed ID: 24664583
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5.
Jiang W; Zheng J; Yu T; Wang J
Oncol Rep; 2017 Aug; 38(2):1099-1107. PubMed ID: 28627703
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells.
Chen P; Wang XL; Ma ZS; Xu Z; Jia B; Ren J; Hu YX; Zhang QH; Ma TG; Yan BD; Yan QZ; Li YL; Li Z; Yu JY; Gao R; Fan N; Li B; Yang JL
Asian Pac J Cancer Prev; 2012; 13(7):3223-8. PubMed ID: 22994738
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo.
Ji SQ; Yao L; Zhang XY; Li XS; Zhou LQ
J Exp Clin Cancer Res; 2012 Mar; 31(1):22. PubMed ID: 22420896
[TBL] [Abstract][Full Text] [Related]
8. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.
Su B; Shi B; Tang Y; Guo Z; Yu X; He X; Li X; Gao X; Zhou L
Prostate; 2015 Jan; 75(1):33-44. PubMed ID: 25307178
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Inducible Factor 1A Upregulates HMGN5 by Increasing the Expression of GATA1 and Plays a Role in Osteosarcoma Metastasis.
Xu E; Ji Z; Jiang H; Lin T; Ma J; Zhou X
Biomed Res Int; 2019; 2019():5630124. PubMed ID: 31930127
[TBL] [Abstract][Full Text] [Related]
10. Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.
Guo Z; Zhang X; Li X; Xie F; Su B; Zhang M; Zhou L
Oncol Rep; 2015 Mar; 33(3):1519-25. PubMed ID: 25572120
[TBL] [Abstract][Full Text] [Related]
11. microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
Wei P; Qiao B; Li Q; Han X; Zhang H; Huo Q; Sun J
DNA Cell Biol; 2016 Jan; 35(1):33-43. PubMed ID: 26394192
[TBL] [Abstract][Full Text] [Related]
12. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines.
Liang G; Xu E; Yang C; Zhang C; Sheng X; Zhou X
Oncol Rep; 2015 Mar; 33(3):1300-6. PubMed ID: 25530340
[TBL] [Abstract][Full Text] [Related]
13. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells.
Song J; Zhang J; Shao J
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):263-9. PubMed ID: 26055549
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
[TBL] [Abstract][Full Text] [Related]
16. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
17. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L
DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587
[TBL] [Abstract][Full Text] [Related]
18. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
Liu X; Ma W; Yan Y; Wu S
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
[TBL] [Abstract][Full Text] [Related]
19. HMGN5: a potential oncogene in gliomas.
Qu J; Yan R; Chen J; Xu T; Zhou J; Wang M; Chen C; Yan Y; Lu Y
J Neurooncol; 2011 Sep; 104(3):729-36. PubMed ID: 21373965
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
